Academician
AYŞEGÜL ATEŞ DEĞİRMENCİ
ARAŞTIRMA GÖREVLİSİ
EGE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Mikrobiyoloji
A quick look at recorded outputs — details below.
- Articles 19
- Projects 0
- Books 1
- Proceedings 10
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
3
Q2
3
Q3
4
Q4
1
WoS (JCR)
Q1
3
Q2
0
Q3
4
Q4
3
TR Index
9
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
4
Avg percentile
49.4%
Top 1% share
0.0%
Top 10% share
25.0%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2026 Effects of empagliflozin and metformin on biofilm formation and pathogenicity factors of urinary Escherichia coli isolates YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 95.5%
- 2026 Targeting biofilm-related genes in a clinical methicillin-resistant Staphylococcus aureus isolate using CRISPR-Cas9 gene editing YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.4%
- 2026 Lipoplex as a useful tool for resensitization of methicillin-resistant Staphylococcus aureus to erythromycin via CRISPR-Cas technology YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.4%
- 2026 Empagliflozin modulates biofilm formation and virulence-associated gene expression in multidrug-resistant Staphylococcus aureus and Acinetobacter baumannii YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.0%
- 2024 Antibacterial activity and cytocompatibility evaluation of cefpodoxime proxetil loaded eudragit rs 100 nanoparticles YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 39.4%
- 2024 CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 91.9%
- 2024 Precision Genome Editing Unveils a Breakthrough in Reversing Antibiotic Resistance: CRISPR/Cas9 Targeting of Multi-Drug Resistance Genes in Methicillin-ResistantStaphylococcus aureus YÖKSİS
- 2024 An innovative approach to biofilm-associated infections: CRISPR/Cas9-Mediated Genetic Intervention. YÖKSİS
- 2023 Bacterial Circadian Rhythm YÖKSİS TR Index OpenAlex 2.5%
- 2021 COVID-19 Pandemisinde Mikrobiyolojik Tanı Yöntemleri YÖKSİS TR Index OpenAlex 8.4%
- 2021 Antimicrobial Activity Evaluation of Newly Synthesized N,N-Disubstituted Taurinamidobenzenesulfonamide Derivatives YÖKSİS TR Index SJR Q4 OpenAlex 34.3%
- 2020 Antifungal and Antibiofilm Activities of SelectiveSerotonin Reuptake Inhibitors Alone and inCombination with Fluconazole YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 65.3%
- 2020 Antifungal and antibiofilm activities of selective serotonin reuptake inhibitors alone and in combination with fluconazole YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 16.3%
- 2011 Vertical Intra industry Trade and Fragmentation An Empirical Examination of the US Auto parts Industry YÖKSİS OpenAlex top 10% OpenAlex 96.8%
- 2026 Comparison of Ion Release and Antibacterial Activity of Zinc-Containing and Conventional Glass Ionomer Cements Under Different pH Conditions: In Vitro Study YÖKSİS OpenAlex 9.0%
- 2024 Antibacterial activity and cytocompatibility evaluation of cefpodoxime proxetil loaded eudragit rs 100 nanoparticles YÖKSİS TR Index SJR Q3 JCR Q4
- 2023 DESIGN OF AZITHROMYCIN LOADED EUDRAGIT RL 100 NANOPARTICLES WITH EXTENDED ANTIBACTERIAL EFFECT YÖKSİS SJR Q2 JCR Q4 OpenAlex 79.5%
- 2021 Antimicrobial activity screening of a series of taurine derivatives YÖKSİS TR Index
- 2021 Microbiological Diagnostic Methods in COVID-19 Pandemic YÖKSİS TR Index OpenAlex 8.4%
- 2020 Alternative Therapy to Antibiotics: CRISPR-Cas antimicrobials YÖKSİS OpenAlex 44.4%